SURFACE COEXPRESSION OF VIBRIO-CHOLERAE AND SALMONELLA-TYPHI O-ANTIGENS ON TY21A CLONE EX210

被引:22
作者
ATTRIDGE, SR
DANIELS, D
MORONA, JK
MORONA, R
机构
[1] Enterovax Limited, C/- Department of Microbiology and Immunology, The University of Adelaide, Adelaide, SA 5001
关键词
bivalent vaccine; O-antigen; Salmonella typhi Ty21a; Vibrio cholerae;
D O I
10.1016/0882-4010(90)90045-R
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In an attempt to construct a bivalent, live, oral cholera-typhoid vaccine, genes specifying the biosynthesis of Vibrio cholerae O-antigen have been transferred into a modified version of the attenuated, oral typhoid vaccine strain Salmonella typhi Ty21a. The present report investigates the production of V. cholerae and S. typhi O-antigens by one such clone, EX210. When cultured without galactose supplementation EX210 produces surface O-antigen of V. cholerae type, as detected by haemagglutination-inhibition and bactericidal assays, and by immuno-electron microscopy. However, the protective efficacy of Ty21a depends upon growth in the presence of exogenous galactose and under these conditions only S. typhi O-antigen is detectable on the surface of EX210. Subsequent experiments revealed that the proportion of polysaccharide of S. typhi type is dependent upon the level of galactose supplementation, and identified a limiting sugar concentration which results in surface co-expression of both O-antigens. Visualization of the two polysaccharides on silver-stained polyacrylamide gels indicates that S. typhi O-antigen subunits are polymerized into longer sidechains, suggesting that at higher galactose concentrations their predominance results in a masking of the shorter V. cholerae O-antigen. © 1990.
引用
收藏
页码:177 / 188
页数:12
相关论文
共 26 条
[1]   PROPHYLACTIC SIGNIFICANCE OF THE NONLIPOPOLYSACCHARIDE ANTIGENS OF VIBRIO-CHOLERAE [J].
ATTRIDGE, SR ;
ROWLEY, D .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) :931-939
[2]   EFFECT OF LIPOPOLYSACCHARIDE STRUCTURE ON REACTIVITY OF ANTIPORIN MONOCLONAL-ANTIBODIES WITH THE BACTERIAL-CELL SURFACE [J].
BENTLEY, AT ;
KLEBBA, PE .
JOURNAL OF BACTERIOLOGY, 1988, 170 (03) :1063-1068
[3]   RESPONSE OF MAN TO INFECTION WITH VIBRIO-CHOLERAE .2. PROTECTION FROM ILLNESS AFFORDED BY PREVIOUS DISEASE AND VACCINE [J].
CASH, RA ;
MUSIC, SI ;
LIBONATI, JP ;
CRAIG, JP ;
PIERCE, NF ;
HORNICK, RB .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (04) :325-333
[4]  
FINKELSTEIN RA, 1984, BACTERIAL VACCINES, P107
[5]  
FORREST B D, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P449
[6]  
Germanier R, 1983, Dev Biol Stand, V53, P3
[7]  
GERMANIER R, 1984, BACTERIAL VACCINES, P137
[8]   ENDEMIC CHOLERA IN RURAL BANGLADESH, 1966-1980 [J].
GLASS, RI ;
BECKER, S ;
HUQ, MI ;
STOLL, BJ ;
KHAN, MU ;
MERSON, MH ;
LEE, JV ;
BLACK, RE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 116 (06) :959-970
[9]   NEW CHOLERA VACCINES [J].
HOLMGREN, J ;
CLEMENS, J ;
SACK, DA ;
SVENNERHOLM, AM .
VACCINE, 1989, 7 (02) :94-96
[10]   DEVELOPMENT OF IMPROVED CHOLERA VACCINE BASED ON SUBUNIT TOXOID [J].
HOLMGREN, J ;
SVENNERHOLM, AM ;
LONNROTH, I ;
FALLPERSSON, M ;
MARKMAN, B ;
LUNDBECK, H .
NATURE, 1977, 269 (5629) :602-604